Jason Davis's most recent trade in FibroBiologics Inc was a trade of 450,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroBiologics Inc | Jason Davis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) |